Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Molecular & Cellular Immunology > Lecture 9: NK Cells > Flashcards

Lecture 9: NK Cells Flashcards

1
Q

What are NK cells?

A

Innate like lymphocytes, which do not express polymorphic clonal receptors like T and B cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What NK functions are similar to CD8 T cells?

A
  • production of perforin and granzyme b to lyse target cells
  • production of IFN-y
  • kill target cells via FAS/FAS-L interactions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

In what ways are NK cells different from CD8 T cells?

A
  • NK cells are not antigen restricted
  • do not require antigen presentation via MHC for activation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the main role of NK cells?

A

Kill infected cells or kill cancer cells as they arise in the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How are NK cells controlled?

A

By a balance between activatory receptors and inhibitory receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How does missing self activation work?

A

If NK cells detect missing MHCI receptors on the cell surface (loss from viral infection or cancer), the cells are identified as non-self and killed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How does self-induced self activation work?

A

Stress ligands can be upregulated in cells, which can be bound by NK cell surface proteins to push activation signalling which becomes strong enough to override inhibitory signals received from binding MHC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What different receptors define NK cells in mice and humans?

A

Mice: expression of NK1.1 in C57Bl6 mice, and Nkp46 in other strains
Humans: expression of CD56

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are examples of activatory receptors?

A

NKG2D, NKp46/44/30, and CD16

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are examples of inhibitory receptors?

A

NKG2A and KIR receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are key features of CD56bright NK cells?

A
  • rare subset in the blood (5%)
  • abundant in certain tissues
  • rapidly produce immunomodulatory cytokines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are key features of CD56dim NK cells?

A
  • dominant subset in peripheral blood
  • play a cytotoxic effector role by releasing granules
  • NK cells that go in and kill target cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are key features of adaptive NK cells?

A
  • long lived NK cells which lack CD56
  • rapidly proliferate and produce cytokines upon viral re-exposure
  • kill target cells with the help of antibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Where are NK cells derived from?

A

Secondary lymphoid organs from common lymphoid progenitors (same as B and T cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What happens as HSCs develop into multipoint progenitor cells (MPPs)?

A

Cells gain CD45, so start to commit to becoming immune cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What happens as MPPs develop into common lymphoid progenitors (CLPs)?

A

Cells gain CD10 and lose CD34 expression, cell can still become pro-B, pre-T or NK precursor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What happens as CLPs develop into NK progenitors (NKPs)?

A

Cell starts to commit to becoming an NK cell, so upregulates CD122, NKG2D and CD7

Acquisition of IL-1R1 marks early commitment to becoming NKP, once CD122 is unregulated they are irreversibly committed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What happens as NKPs develop into immature NK cells (iNK)?

A

Upregulation of activatory molecules NKG2D and NKp46/44/30

18
Q

What happens as iNKs develop into fully committed mature NK cells?

A

CD56 is expressed

19
Q

What experiment was used to test IL-15R importance and what was the outcome?

A
  • transferred NK cells from IL-15R KO mice into either WT mice or IL-15R mice
  • use congenial markers to identify NK cells and survival in both sets
  • NK cells survived in WT mice but died in KO mice
    = IL-15R is required to maintain NK cell numbers
    = IL-15R doesn’t function on NK cell
20
Q

What is IL-15 transpresentation?

A
  • IL15 is not secreted, but is loaded onto a receptor in the ER which is put onto the cell surface
  • is presented to NK cells through cell-cell interactions and allows corresponding singaling cascade to occur
21
Q

What are the 2 main effector pathways of effector mechanisms?

A

Granule mediated cytotoxicity and receptor mediated cytotoxicity

22
Q

How is the immune synapse formed?

A

NK from immune synapse with target cells via integral binding (LFA-1)

23
Q

How does LFA-1 prevent granule diffusion away from the target cells?

A
  • lytic granules are transported along microtubules and fuse with the plasma membrane to be released into the synaptic cleft
  • LFA-1 creates tight junction between cells and holds them in close proximity, preventing diffusion of cytolytic granules out of immune synapse
  • perforin punctures holes, lets granzyme in which interacts with pathways such as caspase activation, mitochondrial dysfunction, and caspase independent apoptosis
24
Q

How do perforin and granzyme kill the target cell?

A
  • neutral pH of extracellular environment allows perforin to insert into the plasma membrane
  • interaction with Ca2+ ions allows colocalisation of perforin monomers to create a channel
  • granzyme passes through the channel and induces target cell death
25
Q

What 3 mechanisms do NK cells use to prevent damaging themselves during granule mediated cytotoxicity?

A

SB9, CD107a, and Cathepsin B

26
Q

What is SB9?

A

A granzyme B inhibitor found in the cytoplasm of NK cells, which acts as a substrate for granzyme B resulting in conformational changes and deactivation of the enzymatic activity

27
Q

What is CD107a?

A

A degranulation marker which is unregulated to the plasma membrane during degranulation and inhibits the binding of perforin to the NK cell plasma membrane

28
Q

What is cathepsin B?

A

Cleaves perforin and prevents insertion into the plasma membrane, as it is expressed at the plasma membrane during degranulation

29
Q

What are the 3 main receptor mediated cytotoxic pathways?

A

Fas/FasL, TRAIL/TRAIL R and TNF

30
Q

What happens in the Fas/FasL pathway?

A
  • FasL binds to Fas
  • Induces activation of caspase 8/10
  • Results in caspase cascade leading to in programmed cell death and apoptosis
31
Q

What happens in the TAIL/TRAIL R pathway?

A
  • triggers caspase activation
  • triggers caspase cascade
  • results in cell death through apoptosis or inhibition of the mitochondria
32
Q

How does TNF induce cell death?

A

TNF can bind to TNFR-1 or 2 which induces apoptosis

33
Q

How does antibody dependent cellular cytotoxicity work?

A
  • Antibodies bind to target antigens on the cell surface (eg. bacterial proteins or viral antigen)
  • Fc receptors on NK cells use CD16 to bind to the Fc region of the antibody antigen complex
  • Cross linking of CD16 signals to NK cells to release intracellular stores of perforin and granzyme
  • perforin punctures holes allowing granzyme to enter and induce apoptosis
34
Q

Why do we need NK cells?

A
  • same function as CD8 T cells but are much faster to respond
  • respond to missing self
  • do not require antigen presentation via MHC
35
Q

What are then main routes of NK immunotherapies?

A
  • Chemokines: NK-specific activation
  • Checkpoint inhibition: immune checkpoint blockade
  • Antibody mediated interventions: neutralising tumour ligands, or blocking inhibitory receptors so they can’t inhibit NK cell function
  • Adoptive transfer of modified cells: engineered CAR NK cells
  • Cytokines: induce NK cell activation (IL-2, IL-15)
  • Tri-specific NK engagers: trigger activator domain on NK cells and bring them into close proximity of tumour cells
35
Q

What are CARs and what are they used for?

A
  • Chimeric antigen receptors, often used with T cells and Nk cells to improve immunotherapy function
  • Combines various intracellular signalling domains with the fragment of antigen binding (FAB) from an Ig = creates super receptor
36
Q

What do CARs do?

A

Lower the activation threshold for NK cells and allow them to bypass many of the inhibitory receptors that would otherwise impede their function in the tumour microenvironment

37
Q

What are chemokines?

A

Chemotactic cytokines which bind to and signal through G protein coupled receptors

38
Q

What are 4 main families of chemokines?

A

CC, CXC, CX3C, and XC

39
Q

What is the purpose of the atypical chemokine receptors?

A

Removes chemokines after an immune response to prevent contact inflammation

40
Q

What is CCL2?

A
  • CCL2 is an inflammatory cytokine which is upregulated during inflammation
  • binds to CCR2 to promote response, and also atypical receptor ACKR2
41
Q

Why do tumours produce a lot of CCL2?

A

Expressed early in tumour production with high potential to draw in macrophages - if tumours bring macrophages to the microenvironment, can turn them into tumour associated macrophages and promote angiogenesis, increase tumour growth ands increase blood supply

42
Q
A

Molecular & Cellular Immunology (14 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions